Sientra (STU:S0Z0) Common Stock : €0.11 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Sientra Common Stock?

Sientra's quarterly common stock declined from Mar. 2023 (€0.11 Mil) to Jun. 2023 (€0.10 Mil) but then increased from Jun. 2023 (€0.10 Mil) to Sep. 2023 (€0.11 Mil).

Sientra's annual common stock declined from Dec. 2020 (€0.42 Mil) to Dec. 2021 (€0.06 Mil) but then increased from Dec. 2021 (€0.06 Mil) to Dec. 2022 (€0.10 Mil).

Sientra Common Stock Historical Data

The historical data trend for Sientra's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sientra Common Stock Chart

Sientra Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Common Stock

Get a 7-Day Free Trial

0.25

0.45

0.42

0.06

0.10

Sientra Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Common Stock	Get a 7-Day Free Trial															0.64	0.10	0.11	0.10	0.11

Sientra Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Sientra (STU:S0Z0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sientra Inc (STU:S0Z0) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SIEN:USA S0Z0:Germany

Address

3333 Michelson Drive, Suite 650, Irvine, CA, USA, 92612

Website

https://www.sientra.com

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.

Sientra (STU:S0Z0) Headlines

No Headlines